nr2f5 Antibody

What is nr2f5 and why is it significant in developmental biology research?

Nr2f5 (nuclear receptor subfamily 2, group F, member 5) is a transcription factor that plays a crucial role in cranial skeletal development, particularly in the transition of cranial neural crest cells to ectomesenchyme. It acts upstream of or within cranial skeletal system development and response to retinoic acid pathways . Research indicates that nr2f5 is expressed in several structures including the anterior neural keel, hindbrain neural keel, mesoderm, nervous system, and pharyngeal arch .

The significance of nr2f5 in research stems from its involvement in developmental processes, particularly in zebrafish models where it has been studied extensively. Studies of nr2f5 mutants have revealed its role in regulating ectomesenchyme genes such as dlx2a, prrx1a, prrx1b, sox9a, twist1a, and fli1a . Understanding nr2f5 function helps elucidate mechanisms of cranial neural crest cell differentiation and skeletal formation.

How do nr2f nuclear receptors relate to each other, and what are the implications for antibody selection?

Nr2f nuclear receptors form a family with highly conserved DNA-binding domains (84-100% identical) and ligand-binding domains (68-97% identical) . This family includes nr2f5 along with other members like nr2f2. The high sequence homology has several implications:

• Cross-reactivity: Antibodies raised against one Nr2f member may cross-react with others

• Specificity challenges: Validating antibody specificity is critical

• Functional redundancy: Multiple Nr2f family members may compensate for each other

When selecting antibodies, researchers should carefully examine:

Understanding these relationships is crucial for interpreting antibody labeling patterns and for designing appropriate controls .

What considerations should guide the selection of an appropriate nr2f5 antibody for developmental studies?

When selecting an nr2f5 antibody for developmental studies, consider:

• Species reactivity: Ensure the antibody recognizes nr2f5 in your model organism. While some antibodies may cross-react across species due to conservation, specific validation is essential .

• Epitope location: Consider whether the antibody targets domains that might be affected by mutations or alternative splicing. For instance, antibodies targeting the N-terminal region versus those targeting the DNA-binding domain may give different results in certain experimental contexts.

• Application compatibility: Verify the antibody has been validated for your specific application (IHC, WB, IP, etc.) .

• Mutation status consideration: If working with mutant models, ensure the antibody's epitope is not affected by the mutation. For example, the ci3000 nr2f5 mutation deletes the 5'UTR and most of the first exon, potentially affecting antibody binding depending on the epitope .

• Cross-reactivity with other Nr2f family members: Due to high sequence homology, carefully evaluate potential cross-reactivity with other Nr2f proteins .

What techniques can be effectively employed to study nr2f5 expression and function?

Multiple techniques can be employed to study nr2f5, each with specific methodological considerations:

Immunohistochemistry (IHC):

• Fixed tissue sections provide spatial information about nr2f5 expression

• Recommended fixation: 4% paraformaldehyde for 24 hours at 4°C

• Antigen retrieval: Heat-induced epitope retrieval in citrate buffer (pH 6.0)

• Antibody concentration: Start with 10μg/ml as used for similar nuclear receptors

• Detection system: Fluorescent secondary antibodies allow co-localization studies

Western Blotting (WB):

• Protein extraction buffer should include protease inhibitors and nuclear extraction reagents

• Expected molecular weight: ~40-45kDa based on related nuclear receptors

• Loading control: Nuclear proteins like Lamin B1 or HDAC1 are appropriate

• Blocking: 5% BSA often works better than milk for nuclear receptor detection

Immunoprecipitation (IP):

• Particularly useful for studying nr2f5 interactions with other proteins

• Cross-linking prior to lysis may help preserve transient interactions

• Pre-clearing lysates reduces background

• Controls should include IgG-only immunoprecipitation

Chromatin Immunoprecipitation (ChIP):

• Valuable for identifying nr2f5 binding sites on DNA

• Crosslinking protocol: 1% formaldehyde for 10 minutes at room temperature

• Sonication conditions must be optimized for 200-500bp fragments

• Sequential ChIP can determine co-occupancy with other factors

How should researchers validate the specificity of nr2f5 antibodies?

Validating nr2f5 antibody specificity is critical due to potential cross-reactivity with other Nr2f family members. A comprehensive validation approach includes:

• Genetic models: Testing antibodies on nr2f5 mutant tissues is the gold standard. The el611 and ci3000 nr2f5 mutants described in the literature provide excellent negative controls .

• Peptide competition assays: Pre-incubating the antibody with the immunizing peptide should abolish specific signal.

• Correlation with mRNA expression: Compare antibody staining patterns with in situ hybridization data for nr2f5.

• Knockdown validation: Use morpholinos or siRNAs to reduce nr2f5 expression and confirm reduced antibody signal.

• Cross-species validation: If nr2f5 is conserved across species, consistent staining patterns in homologous tissues support specificity.

• Multiple antibodies targeting different epitopes: Concordant results with independently generated antibodies increase confidence in specificity.

• Recombinant protein controls: Testing against recombinant nr2f5 and other Nr2f family members can quantify cross-reactivity.

What are the key considerations for using nr2f5 antibodies in zebrafish developmental studies?

Zebrafish are important models for studying nr2f5 function . When using nr2f5 antibodies in zebrafish:

• Developmental timing: Nr2f5 expression changes during development, particularly in cranial neural crest cells transitioning to ectomesenchyme. Sampling at specific hours post-fertilization (hpf) is critical:

  • 18 hpf: Sox10+ CNCCs arrive at the arches

  • 26 hpf: Important timepoint for evaluating ectomesenchyme marker expression

• Fixation protocol: For zebrafish embryos, 4% paraformaldehyde for 2-4 hours at room temperature, followed by methanol dehydration if needed.

• Permeabilization: Additional permeabilization steps with proteinase K (carefully titrated for developmental stage) or Triton X-100 may be necessary.

• Background reduction:

  • Block with 10% normal goat serum, 1% BSA, 0.1% Triton X-100

  • Include 0.1% Tween-20 in all wash steps

  • Consider tyramide signal amplification for weak signals

• Double labeling strategies: Combining nr2f5 antibody with markers for:

  • Neural crest (sox10)

  • Ectomesenchyme (dlx2a, fli1a)

  • Skeletal progenitors (sox9a)

  • These can provide valuable context for interpreting nr2f5 expression patterns

• Mutant resources: Utilize available mutant lines like nr2f5 el611 and ci3000 for controls and functional studies .

How do nr2f5 and nr2f2 interact functionally, and what are the implications for experimental design?

Nr2f5 and nr2f2 demonstrate functional redundancy and cooperation during development, with important implications for experimental design:

• Compensatory mechanisms: Single nr2f5 mutants show initial delays in ectomesenchyme gene expression but eventually recover and form skeletal structures. This suggests compensation by other Nr2f family members, particularly nr2f2 .

• Double mutant analysis: nr2f2;nr2f5 double mutants show more severe phenotypes than single mutants, indicating partial functional redundancy. Experiments targeting nr2f5 should consider this redundancy .

• Expression pattern overlap: Both factors are expressed in cranial neural crest cells, but with slightly different temporal dynamics. Experimental designs should account for these spatiotemporal differences.

• Downstream targets: Both factors regulate overlapping sets of genes, including dlx2a, prrx1a, prrx1b, sox9a, twist1a, and fli1a . ChIP experiments may need to account for binding site co-occupancy.

• Triple mutant considerations: Combining nr2f5 mutations with triple nr2f1a/1b/2 or nr2f2/6a/6b mutations almost completely eliminates facial skeleton formation, suggesting broader functional interactions across the family .

This functional overlap has several methodological implications:

• Antibody studies should include careful controls to distinguish between nr2f5 and nr2f2

• Knockdown experiments may require targeting multiple family members

• Phenotypic analyses should examine potential compensation

How can researchers effectively analyze nr2f5 function in the context of retinoic acid signaling?

Nr2f5, like other Nr2f family members, is involved in retinoic acid (RA) signaling . Effective experimental approaches include:

• RA manipulation experiments:

  • Treatment with exogenous RA (0.1-1μM) at specific developmental windows

  • Application of RA synthesis inhibitors (e.g., DEAB)

  • Use of heat-shock inducible transgenic lines expressing dominant-negative RA receptors

• Reporter systems:

  • RARE-luciferase reporters to monitor RA activity

  • Dual reporter systems to simultaneously track nr2f5 expression and RA activity

• Molecular analyses:

  • ChIP-seq to identify nr2f5 binding sites in the context of RA treatment

  • RNA-seq to determine transcriptional changes in wild-type versus nr2f5 mutants with and without RA manipulation

• Protein interaction studies:

  • Co-immunoprecipitation of nr2f5 with RA receptors (RARs and RXRs)

  • Proximity ligation assays to detect protein associations in situ

• Domain mapping:

  • Structure-function analysis using constructs with mutations in the ligand-binding domain, which may be activated by high concentrations of 9-cis-retinoic acid and all-trans-retinoic acid (based on data from related nr2f proteins)

A comprehensive experimental design would integrate these approaches to elucidate how nr2f5 functions within the RA signaling network during development.

What techniques can be used to investigate the role of nr2f5 in ectomesenchyme fate determination?

Investigating nr2f5's role in ectomesenchyme fate determination requires approaches that address both phenotypic outcomes and molecular mechanisms:

• Lineage tracing:

  • Utilize photoconvertible fluorescent proteins under nr2f5 or neural crest promoters

  • Cre-lox based lineage tracing with nr2f5-Cre or tamoxifen-inducible CreERT2 systems

  • Time-lapse imaging of labeled cells to track migration and differentiation

• Transcriptional profiling:

  • Single-cell RNA-seq to identify distinct cell populations and transitions

  • Bulk RNA-seq comparing wild-type and nr2f5 mutant neural crest at key developmental stages (18 hpf, 26 hpf)

  • Spatial transcriptomics to maintain positional information

• Transgenic reporter lines:

  • Dual reporters such as sox10:DsRed (neural crest) and fli1a:EGFP (ectomesenchyme/vasculature) to visualize the ectomesenchyme transition in real-time

  • Reporter lines for additional ectomesenchyme markers (dlx2a, prrx1a, sox9a)

• Genetic interaction studies:

  • Cross nr2f5 mutants with sox10 mutants (which showed rescue of skeletal development in nr2f5 single mutants)

  • Generate nr2f5;nr2f2 double mutants to assess redundancy

  • Test interactions with other ectomesenchyme regulators

• Chromatin studies:

  • ATAC-seq to identify changes in chromatin accessibility

  • ChIP-seq to map nr2f5 binding sites near ectomesenchyme genes

  • HiC or other chromosome conformation capture techniques to identify long-range interactions

The study by Okeke et al. (2022) provides foundational data showing that nr2f5 mutants display marked delays in upregulation of ectomesenchyme genes and in downregulation of sox10, which is normally restricted to early neural crest and non-ectomesenchyme lineages .

What are common challenges in detecting nr2f5 protein and how can they be addressed?

Researchers may encounter several challenges when detecting nr2f5:

• Low expression levels:

  • Solution: Use signal amplification methods such as tyramide signal amplification (TSA) or polymer-based detection systems

  • Increase sensitivity by using high-affinity monoclonal antibodies

  • Optimize protein extraction for nuclear proteins (using specialized nuclear extraction buffers)

• Cross-reactivity with other Nr2f family members:

  • Solution: Pre-absorb antibodies with recombinant related proteins

  • Use peptide competition controls

  • Validate with genetic models (nr2f5 mutants)

  • Consider using two antibodies targeting different epitopes

• Nuclear localization challenges:

  • Solution: Ensure proper nuclear permeabilization (0.5% Triton X-100 for 20 minutes)

  • Use antigen retrieval (heat-induced epitope retrieval in citrate buffer)

  • Include appropriate nuclear markers as positive controls

• Background staining:

  • Solution: Increase blocking stringency (5% BSA, 5% normal serum, 0.3% Triton X-100)

  • Reduce primary antibody concentration

  • Include additional washing steps with 0.1% Tween-20

  • Use proper negative controls (IgG control, secondary-only control)

• Temporal regulation of expression:

  • Solution: Sample multiple developmental timepoints

  • Use positive controls for known expression domains

  • Reference published expression data for appropriate timing

How can the specificity of nr2f5 antibodies be improved for complex tissue analyses?

Improving specificity for nr2f5 detection in complex tissues:

• Antibody affinity purification:

  • Purify polyclonal antibodies against the immunizing peptide

  • Remove cross-reactive antibodies by pre-absorption with related proteins

• Multi-step detection protocol:

  • Use primary antibodies from different host species for nr2f5 and other Nr2f family members

  • Employ spectrally distinct fluorophores for simultaneous detection

  • Analyze co-localization quantitatively

• Tissue-specific validation:

  • Validate antibodies specifically in each tissue of interest

  • Compare with in situ hybridization data for the same tissues

  • Use tissue-specific knockouts or knockdowns as controls

• Combinatorial marker analysis:

  • Use co-detection with established markers of cell types known to express nr2f5

  • Apply unsupervised clustering algorithms to distinguish true signal from background

• Advanced microscopy techniques:

  • Super-resolution microscopy for precise subcellular localization

  • Spectral imaging to separate overlapping fluorophore signals

  • FRET-based approaches to confirm proximity with known interaction partners

What controls should be included when using nr2f5 antibodies in experimental procedures?

Comprehensive control strategies for nr2f5 antibody experiments:

Negative controls:

• Genetic controls: Tissues from nr2f5 mutants (e.g., el611, ci3000)

• Antibody controls:

  • Isotype-matched irrelevant antibody

  • Secondary antibody only

  • Primary antibody pre-absorbed with immunizing peptide

• Tissue controls: Samples from tissues known not to express nr2f5

Positive controls:

• Expression validation: Tissues with documented nr2f5 expression (e.g., pharyngeal arches in zebrafish at 26 hpf)

• Recombinant protein: Western blots with recombinant nr2f5 protein

• Overexpression systems: Cells transfected with nr2f5 expression constructs

Specificity controls:

• Cross-reactivity assessment: Testing on tissues expressing other Nr2f family members

• Correlation controls: Parallel analysis with in situ hybridization

• Antibody panel: Using multiple antibodies targeting different nr2f5 epitopes

Technical controls:

• Loading controls: Appropriate housekeeping proteins for Western blots

• Signal intensity controls: Calibration standards for quantitative analysis

• Processing controls: Samples processed identically except for primary antibody

How are nr2f5 antibodies being utilized to understand the genetic networks governing cranial development?

Nr2f5 antibodies are becoming valuable tools for elucidating the genetic networks governing cranial development:

• Chromatin immunoprecipitation sequencing (ChIP-seq):

  • Identifying direct nr2f5 target genes in developing cranial neural crest

  • Mapping the enhancer landscape regulated by nr2f5

  • Studies suggest nr2f5 broadly activates skeletal progenitor genes in post-migratory cranial neural crest cells

• Multi-omics integration:

  • Combining ChIP-seq with RNA-seq to correlate binding and expression changes

  • Integrating ATAC-seq to understand chromatin accessibility changes regulated by nr2f5

  • These approaches help construct gene regulatory networks centered on nr2f5

• Proteomic approaches:

  • Immunoprecipitation followed by mass spectrometry to identify nr2f5 protein complexes

  • Proximity labeling techniques (BioID, APEX) to map the nr2f5 protein interaction network

  • Understanding co-factor requirements for nr2f5 function

• Spatiotemporal analysis:

  • Combining antibody staining with high-resolution imaging to create expression atlases

  • Correlating nr2f5 protein localization with expression of ectomesenchyme genes like dlx2a, prrx1a, prrx1b, sox9a, twist1a, and fli1a

• Cross-species comparative studies:

  • Using nr2f5 antibodies across model organisms to identify conserved and divergent aspects of cranial development

  • Studies in zebrafish have revealed that mutation of sox10 fully rescued skeletal development in nr2f5 single mutants but not nr2f2;nr2f5 double mutants

What new methodological approaches are being developed for studying nr2f5 in developmental contexts?

Emerging methodological approaches for studying nr2f5 include:

• CRISPR-based approaches:

  • Precise genome editing to create domain-specific mutations

  • CRISPRi/CRISPRa for temporal control of nr2f5 expression

  • Base editing to introduce specific amino acid substitutions

• Live imaging techniques:

  • Antibody-based fluorescent reporters for living systems

  • CRISPR knock-in of fluorescent tags at the endogenous nr2f5 locus

  • Light-sheet microscopy for whole-embryo imaging with cellular resolution

• Single-cell technologies:

  • Single-cell ChIP-seq to understand cell-type-specific binding patterns

  • Single-cell ATAC-seq to map chromatin accessibility in nr2f5-expressing cells

  • Spatial transcriptomics to maintain positional information while assessing gene expression

• Tissue-specific approaches:

  • Conditional knockout systems for tissue-specific nr2f5 deletion

  • Cell type-specific ChIP using Cre-driven biotin tagging of nr2f5

  • Tissue-specific proteomics to identify context-dependent interaction partners

• Functional genomics screens:

  • CRISPR screens to identify genetic interactors of nr2f5

  • Enhancer screens to map nr2f5-responsive regulatory elements

  • Chemical genetic screens to identify small molecule modulators of nr2f5 activity

These emerging approaches promise to provide deeper insights into the complex functions of nr2f5 in development, particularly in the context of cranial neural crest differentiation and skeletal formation.